| Dr Alan Feller, DO | |
|
287 Northern Blvd, Suite 200, Great Neck, NY 11021-4700 | |
| (516) 487-3797 | |
| (516) 466-8356 |
| Full Name | Dr Alan Feller |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 287 Northern Blvd, Great Neck, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730550476 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 198325 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alan Feller, DO 287 Northern Blvd, Suite 200, Great Neck, NY 11021-4700 Ph: (516) 487-3797 | Dr Alan Feller, DO 287 Northern Blvd, Suite 200, Great Neck, NY 11021-4700 Ph: (516) 487-3797 |
News Archive
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has begun Phase 1/2a clinical testing with its lead compound, Glymera(PB1023), in patients with Type 2 diabetes.
​Researchers at Aarhus University, Denmark, have drawn up the most detailed 'image of the enemy' to date of one of the body's most important players in the development of Parkinson's disease.
Melinda Gates of the Bill & Melinda Gates Foundation writes in an opinion piece in Nigeria's Vanguard, "My top priority as a co-chair of the foundation I run with my husband is making sure that all families have access to safe and effective contraception tools that empower them to make a decision about what's best for them and their family. And that means encouraging aid donors and governments here in Nigeria and across Africa to make family planning a priority."
Cancer Research UK and its commercial arm, Cancer Research Technology ("CRT"), are to join forces with Astellas Pharma Inc. (Tokyo, President & CEO: Yoshihiko Hatanaka, "Astellas") to find new drug targets in the fight against cancer, with an initial focus on pancreatic cancer.
Researchers from Israel recently isolated a set of SARS-CoV-2 neutralizing monoclonal antibodies from blood samples of patients with severe COVID-19. They were the first to show that transgenic K18-hACE2 mice infected with lethal doses of SARS-CoV-2 can be fully protected by administering antibodies even 3 days after infection
› Verified 8 days ago
Sohrab Virk, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 611 Northern Blvd, Great Neck, NY 11021 Phone: 516-723-2663 | |
Sai Khee Wong, General Practice Medicare: Not Enrolled in Medicare Practice Location: 355 East Shore Rd., Great Neck, NY 11024 Phone: 718-961-3211 | |
Dr. Stephen M Silverman, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 560 Northern Blvd, Suite 201, Great Neck, NY 11021 Phone: 516-482-4060 Fax: 516-482-4063 | |
Aliza Hakimian, General Practice Medicare: Not Enrolled in Medicare Practice Location: 15 Hill Park Ave Apt 2n, Great Neck, NY 11021 Phone: 516-829-5017 | |
Dr. Deborah Jean Steiner, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 4 Rose Ave, Great Neck, NY 11021 Phone: 516-446-6893 | |
Gidon Akler, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 287 Northern Blvd Ste 108, Great Neck, NY 11021 Phone: 516-453-0764 |